Patient safety extends far beyond the approval and distribution of a pharmaceutical product. Once a medicine enters the market or becomes available through special access programs, continuous monitoring of its safety profile becomes essential to ensuring that healthcare professionals and patients continue to benefit from its therapeutic value. At Iberimed S.A., our Pharmacovigilance Support services are designed to help pharmaceutical manufacturers, biotechnology companies, healthcare institutions, and regulatory partners maintain the highest standards of drug safety through comprehensive monitoring, reporting, and compliance management.
Pharmacovigilance is a vital component of modern healthcare, providing the systems and processes necessary to identify, assess, understand, and prevent adverse effects or any other medicine-related problems. As pharmaceutical products become increasingly innovative and global distribution networks continue to expand, effective pharmacovigilance has become more important than ever. Our dedicated team supports clients throughout the product lifecycle, ensuring that safety information is collected, evaluated, documented, and communicated in accordance with international regulatory requirements and industry best practices.
Every adverse event report represents valuable clinical information that contributes to a better understanding of a medicine’s safety profile. Iberimed S.A. approaches every pharmacovigilance activity with scientific integrity, regulatory precision, and an unwavering commitment to protecting patient health. By combining operational expertise with robust quality systems, we help clients strengthen their pharmacovigilance programs while maintaining confidence among healthcare professionals, regulatory authorities, and patients.
Effective pharmacovigilance requires a structured framework capable of managing safety information from multiple sources while ensuring timely reporting and regulatory compliance. Iberimed S.A. provides end-to-end pharmacovigilance support that encompasses adverse event intake, case processing, medical information management, literature monitoring, safety documentation, follow-up activities, and regulatory submissions. Our integrated approach enables pharmaceutical companies to manage safety obligations efficiently while maintaining complete oversight of their pharmacovigilance activities.
We work closely with marketing authorization holders, clinical research organizations, healthcare providers, and pharmaceutical manufacturers to establish customized pharmacovigilance processes tailored to the specific requirements of each product and market. Whether supporting commercial medicines, orphan drugs, biologics, specialty therapies, compassionate use programs, or clinical trial products, our experienced professionals ensure every safety report is managed with accuracy, confidentiality, and regulatory diligence.
Timeliness is critical in pharmacovigilance. Our operational procedures are designed to ensure that adverse events and safety information are evaluated promptly, documented accurately, and submitted within applicable regulatory timelines. This proactive approach minimizes compliance risks while enabling our clients to maintain continuous oversight of product safety throughout the product lifecycle.
Pharmacovigilance operates within one of the most highly regulated areas of the pharmaceutical industry. Iberimed S.A. maintains comprehensive quality management systems that govern every pharmacovigilance activity, ensuring compliance with international guidelines, Good Pharmacovigilance Practices (GVP), national regulatory requirements, and applicable global safety reporting standards. Our structured processes provide complete traceability, consistency, and accountability across every stage of safety management.
Quality assurance is embedded into every aspect of our pharmacovigilance operations. Standard operating procedures, documented workflows, internal quality reviews, data verification processes, and continuous compliance monitoring help ensure the accuracy, integrity, and completeness of every safety record. Our experienced professionals remain informed of evolving regulatory expectations, enabling clients to navigate changing pharmacovigilance requirements with confidence.
Beyond regulatory compliance, we believe pharmacovigilance should serve as a valuable source of clinical insight. Through careful evaluation of safety data, trend analysis, and ongoing risk assessment, we help clients better understand the real-world performance of their products while supporting informed decision-making regarding patient safety, product development, and lifecycle management.
At Iberimed S.A., pharmacovigilance is more than a regulatory obligation—it is a fundamental responsibility to patients, healthcare professionals, and the global healthcare community. Every safety report processed, every risk evaluated, and every regulatory submission completed contributes to the ongoing effort to improve therapeutic outcomes and protect public health. Our commitment to excellence ensures that pharmacovigilance activities remain scientifically rigorous, operationally efficient, and fully aligned with international healthcare standards.
Our collaborative approach enables us to work seamlessly with pharmaceutical companies, biotechnology innovators, regulatory authorities, healthcare providers, and research organizations to develop pharmacovigilance solutions that support both compliance and long-term business success. Through open communication, technical expertise, and responsive service, we become a trusted extension of our clients’ safety and regulatory teams.
As pharmaceutical innovation continues to transform the future of medicine, Iberimed S.A. remains dedicated to advancing patient safety through comprehensive Pharmacovigilance Support. By combining regulatory expertise, robust quality systems, scientific knowledge, and an unwavering commitment to excellence, we help ensure that every medicine continues to be monitored responsibly throughout its lifecycle—strengthening confidence in healthcare, protecting patients, and contributing to safer therapeutic outcomes worldwide.
Connect with the Experts Behind Reliable Healthcare Solutions
Office
support@iberimed-pharma.com
Phone No.
+34 612 570 839
Opening Hours
Mon – Fri : 10:00am – 05:00pm
Sat – Sun : Closes
Iberimed S.A. is a trusted pharmaceutical distribution and healthcare logistics company committed to connecting manufacturers, healthcare providers, pharmacies, hospitals, and patients through reliable supply chain solutions.
+34 612 570 839
C. de Serrano Galvache, 56Cdad. Lineal, 28033 Madrid, Spain
support@iberimed-pharma.com
©Copyright 2026 IBERIMED S.A. All rights reserved.
